Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines.
Journal: JCO oncology practice
Published: September 24, 2025
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort.
Journal: Translational oncology
Published: May 24, 2025
Treatment tolerability associated with carboplatin dose based on actual versus adjusted body weight in patients with a body mass index ≥25 kg/m2 with advanced ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 21, 2025
PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 01, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study.
Journal: Future oncology (London, England)
Published: November 08, 2024
Endoscopic In Vivo Hyperspectral Imaging for Head and Neck Tumor Surgeries Using a Medically Approved CE-Certified Camera with Rapid Visualization During Surgery.
Journal: Cancers
Published: October 17, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 16, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.
Journal: Cancer research communications
Published: May 24, 2024
Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer.
Journal: Investigational new drugs
Published: May 22, 2024
Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer.
Journal: Gynecologic oncology reports
Published: March 18, 2024
Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Journal: Gynecologic oncology
Published: March 17, 2024
Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine.
Journal: JCO oncology practice
Published: September 18, 2023
Last Updated: 09/26/2026